Opana ER (Oxymorphone)–Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C

Oxymorphone is a semisynthetic extended release opiate used to treat moderate to severe chronic pain. The Food and Drug Administration approved the oral form of oxymorphone available as Opana and Opana ER (extended release) since 2006. The Food and Drug Administration and the Centers for Disease Con...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehmood, Hassan, Khan, Muzammil, Marwat, Asghar, Joshi, Medha, Malhotra, Varun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802609/
https://www.ncbi.nlm.nih.gov/pubmed/29435466
http://dx.doi.org/10.1177/2324709618756423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802609/
https://www.ncbi.nlm.nih.gov/pubmed/29435466
http://dx.doi.org/10.1177/2324709618756423

Ejemplares similares